Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

F. Hoffmann-La Roche discloses HBsAg inhibitors

Aug. 25, 2016

Basilea Pharmaceutica patents MAPK inhibitors

Aug. 25, 2016

FORMA Therapeutics describes HDAC inhibitors

Aug. 24, 2016

FORMA Therapeutics patents HDAC 6 inhibitors

Aug. 23, 2016

Sanford-Burnham Medical Research Institute reports glucocorticoid receptor translocation inhibitors

Aug. 23, 2016

Novo Nordisk divulges neuropeptide Y receptor agonists

Aug. 23, 2016

Trillium Therapeutics patents EGFR inhibitors

Aug. 23, 2016

FORMA Therapeutics discloses ubiquitin hydrolase inhibitors

Aug. 23, 2016

Chinese scientists present Nav1.7 channel blockers

Aug. 22, 2016

Cancer Research Technology develops ENPP2 inhibitors

Aug. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...